- Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
- Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
- Enovis Announces Fourth Quarter and Full Year 2023 Results
- Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
- Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
- Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
- Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
- Enovis Introduces the DonJoy ROAM™ OA Knee Brace
- Enovis 完成对 LimaCorporate S.p.A 的收购
- Enovis 完成對 LimaCorporate S.p.A 的收購
More ▼
Key statistics
On Thursday, Enovis Corp (E2NO34:SAO) closed at 66.47, 4.25% above its 52-week low of 63.76, set on Dec 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 66.47 |
---|---|
High | 66.47 |
Low | 66.47 |
Bid | 70.90 |
Offer | 71.25 |
Previous close | 66.47 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Apr 25 2024 20:49 BST.
More ▼